Naturalistic treatment and follow-up for youth with bipolar spectrum disorders
Official title: A Collaborative Treatment Network for Youth With or at High Risk for Bipolar Disorder
Run by University of California, Los Angeles · NCT05427123 · Data updated 2026-11-12
This study looks at young people aged 9 to 19 with bipolar spectrum disorders to see how well they do over a year while receiving standard treatments and tracking their progress.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 9 Years to 19 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | University of California, Los Angeles Academic / other |
| Locations | 4 sites (Los Angeles, California and 3 other locations) |
| Status | Recruiting |
| Started | July 1, 2022 |
| Main results expected | January 1, 2027 |
| Study ends | July 1, 2027 |
| Registry record updated | February 5, 2026 |
| Trial ID | NCT05427123 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are youth aged 9 to 19 diagnosed with bipolar disorder or related conditions who can participate in assessments with their caregivers.
✕Probably not a fit
Patients with autism spectrum disorder or those with recent substance abuse issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on youth aged 9 to 19 diagnosed with bipolar spectrum disorders across four US sites. It aims to reliably diagnose these youth and examine predictors of clinical outcomes over a 12-month period. Participants will undergo a structured diagnostic interview and a blood draw to measure inflammatory markers, followed by multiple follow-up visits involving interviews and questionnaires. The study will track medication management and psychosocial treatments as per established guidelines.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies and outcomes for youth with bipolar spectrum disorders.
How similar studies have gone: Other studies have shown success in similar approaches, particularly in optimizing treatments for pediatric bipolar disorders.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Youth 9-19 years old * Youth diagnosed with Bipolar disorder (I, II, Other Specified) or Cyclothymic Disorder by the study team during the diagnostic interview screening * Youth is able to read and communicate in English to the degree necessary to be able to assent and participate (with help) in their treatment and assessments appropriate for ages 9 and up * Youth has a caregiver able to participate in ongoing basis in assessment and treatment * The participating caregiver can reliably read and communicate in English for purposes of study consenting, assessment, and treatment, unless preferred language translation services are regularly available. Exclusion Criteria: * Youth has DSM-5 diagnosis of autism spectrum disorder * Youth has DSM-5 diagnosis of substance or alcohol abuse with impairment within 3 mos. * Youth has a medical or psychiatric disorder that is life-threatening or requires immediate hospitalization or emergency medical or therapeutic treatment * Evidence of recent sexual or physical abuse of the youth by legally responsible caregivers * Evidence of recent intimate partner violence between caregivers responsible for the youth's care
Where it's running
-
University of California, Los Angeles, Max Gray Child and Adolescent Mood Disorders Program (CHAMP)
Los Angeles, California, United States Recruiting -
University of Colorado Anschutz Medical Campus, Helen and Arthur E. Johnson Depression Center
Aurora, Colorado, United States Enrolling by invitation -
University of Pittsburgh Child and Adolescent Bipolar Spectrum Services Clinic (CABS)
Pittsburgh, Pennsylvania, United States Enrolling by invitation -
Virginia Commonwealth University Medical Center
Richmond, Virginia, United States Enrolling by invitation
Study contacts
- Principal investigator: David J Miklowitz, PhD — University of California, Los Angeles
- Study coordinator: David J Miklowitz, PhD
- Email: dmiklowitz@mednet.ucla.edu
- Phone: (310) 267-2659
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized weight-loss medication plan for adults with bipolar disorder
This pilot tests whether matching FDA-approved weight-loss medicines to specific obesity types helps adults aged 18–65 with bipolar disorder lose weight.
-
Assessing mental health disorders in Hong Kong using a new recall method
This study is testing a new way to help people in Hong Kong remember important life events to see how many have experienced major depression and thoughts of suicide.
-
Oral icalcaprant for adults with bipolar I or II: safety and symptom change
This trial will test whether taking oral icalcaprant once daily for six weeks is safe and helps reduce depressive symptoms in adults with bipolar I or II disorder.
-
Synchronized eating for bipolar depression
This trial will test whether limiting eating to a 10-hour daily window plus usual care helps adults aged 18–55 with bipolar depression compared with nutritional counselling plus usual care.
-
Understanding factors affecting children and adolescents in the child welfare system
This study looks at the mental and physical health of children and teens in the child welfare system to see how they change over two years.
-
SCC Deep Brain Stimulation for Bipolar Depression in Bipolar I Patients
A small study tests whether deep brain stimulation of the subcallosal cingulate can help people with bipolar I depression who have not improved with other treatments, while monitoring brain signals to watch for manic switches.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.